91
Growth Score
pts
Heat Score
91 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Private molecular diagnostics company. Developed the Idylla™ Platform.
- Roger Moody: CEO at Biocartis NVPast Role: GlySure, Founder & Chief Executive Officer
Randy Polonsky: CFO at Biocartis NV
About the Company
Biocartis is an innovative molecular diagnostics company committed to revolutionizing molecular testing with its unique proprietary IdyllaTM Platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology. Today,
Biocartis offers tests supporting lung, skin, thyroid, colorectal, endometrial, blood, brain and breast cancer.
Biocartis is a privately held company, headquartered in Mechelen, Belgium.
